NKGen Biotech, Inc.

NKGen Biotech is a clinical-stage biotechnology company harnessing the power of the body's immune system through the development and commercialization of innovative autologous, allogeneic and CAR-NK natural killer cell therapies to treat neurodegenerative and oncological diseases utilizing our proprietary SNK (super-activated) platform. The mission of NKGen Biotech is to improve patients' lives in a safe and natural way through innovative cell therapy products and to ultimately become the global leader in immune cell therapeutics. More information can be found on our website www.nkgenbiotech.com